Carlyle, SK Capital Partners disclose expected closing date of bluebird bio deal
Written by Emily J. Thompson, Senior Investment Analyst
Source: SeekingAlpha
Deal Closure Date: Carlyle, SK Capital Partners, and Beacon Parent Holdings are set to finalize their acquisition of bluebird bio on June 2.
Shareholder Options: Bluebird bio shareholders can choose between receiving $3 per share in cash plus a contingent value right or $5 per share in cash without the CVR.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
